School performance,psychiatric comorbidity,and healthcare utilization in pediatric multiple sclerosis: A nationwide population-based observational study
Restricted accessResearch articleFirst published online February, 2021
School performance,psychiatric comorbidity,and healthcare utilization in pediatric multiple sclerosis: A nationwide population-based observational study
Pediatric multiple sclerosis (MS) may hamper educational achievements due to psychiatric comorbidity and cognitive impairment. Our aims were to investigate school performance, psychiatric comorbidity, and healthcare utilization following pediatric MS and to differentiate between disability in MS and that arising from a non-brain-related chronic disease.
Methods:
We included all children (<18 years) with MS onset during 2008–2015 in Denmark with a medical record–validated MS diagnosis. The control groups were children from the general population or children with non-brain-related chronic diseases. Outcomes were register-based on 9–12 grade point average, psychiatric comorbidity, and healthcare visits.
Results:
Cohorts were children with MS (n = 92), control children matched to children with MS (n = 920), children with non-brain-related chronic diseases (n = 9108), and “healthy” children with neither MS nor brain-related chronic disease (n = 811,464). School performance in grades 9–12 was similar, but children with MS compared to those with non-brain-related chronic disease had an almost doubled hazard for psychiatric comorbidity (hazard ratio = 1.87; 95% confidence interval = 1.38–2.53; p < 0.0001) and a higher rate of all hospital visits (p < 0.0001) but a lower rate of hospital admissions (p = 0.001).
Conclusion:
Children with MS have a seemingly standard school performance but increased psychiatric comorbidity and a high rate of healthcare utilization.
RenouxCVukusicSMikaeloffY, et al. Natural history of multiple sclerosis with childhood onset. N Engl J Med2007; 356(25): 2603–2613.
2.
BanwellBLAndersonPE. The cognitive burden of multiple sclerosis in children. Neurology2005; 64(5): 891–894.
3.
BoesenMSThygesenLCUldallPV, et al. Psychiatric morbidity develops after onset of pediatric multiple sclerosis: A Danish nationwide population-based study. Mult Scler Relat Disord2017; 19: 30–34.
4.
BoesenMSMagyariMKoch-HenriksenN, et al. Pediatric-onset multiple sclerosis and other acquired demyelinating syndromes of the central nervous system in Denmark during 1977-2015: A nationwide population-based incidence study. Mult Scler2018; 24(8): 1077–1086.
5.
McKayKAManouchehriniaABerriganL, et al. Long-term cognitive outcomes in patients with pediatric-onset vs adult-onset multiple sclerosis. JAMA Neurol2019; 76: 1028–1034.
6.
HuppkeBEllenbergerDRosewichH, et al. Clinical presentation of pediatric multiple sclerosis before puberty. Eur J Neurol2014; 21(3): 441–446.
7.
GormanMPHealyBCPolgar-TurcsanyiM, et al. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol2009; 66(1): 54–59.
WeisbrotDMEttingerABGadowKD, et al. Psychiatric comorbidity in pediatric patients with demyelinating disorders. J Child Neurol2010; 25(2): 192–202.
10.
AmatoMPGorettiBGhezziA, et al. Cognitive and psychosocial features of childhood and juvenile MS. Neurology2008; 70(20): 1891–1897.
11.
MacAllisterWSBelmanALMilazzoM, et al. Cognitive functioning in children and adolescents with multiple sclerosis. Neurology2005; 64(8): 1422–1425.
12.
Al-SakranLHMarrieRABlackburnDF, et al. Predictors of hospitalization in a Canadian MS population: A matched cohort study. Mult Scler Relat Disord2020; 41: 102028.
13.
MarrieRAElliottLMarriottJ, et al. Comorbidity increases the risk of hospitalizations in multiple sclerosis. Neurology2015; 84(4): 350–358.
14.
KruppLBTardieuMAmatoMP, et al. International pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: Revisions to the 2007 definitions. Mult Scler2013; 19(10): 1261–1267.
15.
BoesenMSBlinkenbergMKoch-HenriksenN, et al. Implications of the International Paediatric Multiple Sclerosis Study Group consensus criteria for paediatric acute disseminated encephalomyelitis: A nationwide validation study. Dev Med Child Neurol2018; 60(11): 1123–1131.
16.
BoesenMSMagyariMBornAP, et al. Pediatric acquired demyelinating syndromes: A nationwide validation study of the Danish National Patient Register. Clin Epidemiol2018; 10: 391–399.
17.
LyngeESandegaardJLReboljM. The Danish National Patient Register. Scand J Public Health2011; 39(7 Suppl.): 30–33.
18.
Koch-HenriksenNRasmussenSStenagerE, et al. The Danish Multiple Sclerosis registry: History, data collection and validity. Dan Med Bull2001; 48(2): 91–94.
19.
FonagerKSørensenHTRasmussenSN, et al. Assessment of the diagnoses of Crohn’s disease and ulcerative colitis in a Danish hospital information system. Scand J Gastroenterol1996; 31(2): 154–159.
20.
KristensenJKDrivsholmTBCarstensenB, et al. [Validation of methods to identify known diabetes on the basis of health registers]. Ugeskr Laeger2007; 169(18): 1687–1692.
21.
LinauskasAOvervadKJohansenMB, et al. Positive predictive value of first-time rheumatoid arthritis diagnoses and their serological subtypes in the Danish National Patient Registry. Clin Epidemiol2018; 10: 1709–1720.
22.
PedersenCB. The Danish Civil registration system. Scand J Public Health2011; 39(7 Suppl.): 22–25.
23.
ThygesenLCDaasnesCThaulowI, et al. Introduction to Danish (nationwide) registers on health and social issues: Structure, access, legislation, and archiving. Scand J Public Health2011; 39(7Suppl.): 12; 39(7 Suppl.): 12–16.
VernalDLStenstrømADStaalN, et al. Validation study of the early onset schizophrenia diagnosis in the Danish psychiatric central research register. Eur Child Adolesc Psychiatry2018; 27(8): 965–975.
26.
UggerbyPØstergaardSDRøgeR, et al. The validity of the schizophrenia diagnosis in the Danish psychiatric central research register is good. Dan Med J2013; 60(2): A4578.
27.
LauritsenMBJørgensenMMadsenKM, et al. Validity of childhood autism in the Danish psychiatric central register: Findings from a cohort sample born 1990-1999. J Autism Dev Disord2010; 40(2): 139–148.
28.
Mohr-JensenCVinkel KochSBriciet LauritsenM, et al. The validity and reliability of the diagnosis of hyperkinetic disorders in the Danish psychiatric central research registry. Eur Psychiatry2016; 35: 16–24.
29.
BockCBukhJDVinbergM, et al. Validity of the diagnosis of a single depressive episode in a case register. Clin Pract Epidemiol Ment Health CP EMH2009; 5: 4.
30.
AndersenJSOlivariusNDFKrasnikA. The Danish national health service register. Scand J Public Health2011; 39(7 Suppl.): 34–37.
31.
KildemoesHWSørensenHTHallasJ. The Danish national prescription registry. Scand J Public Health2011; 39(7 Suppl.): 38–41.
32.
LinDYWeiLJYingZ. Checking the Cox model with cumulative sums of martingale-based residuals. Biometrika1993; 80(3): 557–572.
33.
LinDYWeiLJYangI, et al. Semiparametric regression for the mean and rate functions of recurrent events. J R Stat Soc Ser B Stat Methodol2000; 62(4): 711–730.
34.
AmatoMPKruppLBCharvetLE, et al. Pediatric multiple sclerosis: Cognition and mood. Neurology2016; 87(9 Suppl. 2): S82–S87.
35.
RoccaMAAbsintaMAmatoMP, et al. Posterior brain damage and cognitive impairment in pediatric multiple sclerosis. Neurology2014; 82(15): 1314–1321.
